Mohammadali Ahmadi | Enhanced Oil Recovery | Best Researcher Award

Prof. Mohammadali Ahmadi | Enhanced Oil Recovery | Best Researcher Award

Researcher at University of Technology (SUT), Iran

Dr. Mohammadali Ahmadi is a highly accomplished researcher and academic currently affiliated with the University of Calgary and the Petroleum University of Technology. With a research career spanning over a decade, Dr. Ahmadi has made significant contributions to the fields of petroleum engineering, energy systems, and molecular simulation. His innovative work focuses on improving recovery processes in heavy oil reservoirs, enhancing surfactant applications, and applying molecular dynamics and machine learning to address complex challenges in oil and gas systems. With over 185 publications and more than 8,400 citations, his research has not only advanced scientific understanding but also shaped practical applications in energy engineering and sustainable resource development.

Profile

Orcid

Education

Dr. Ahmadi’s academic foundation is rooted in petroleum engineering, where he earned his advanced degrees specializing in enhanced oil recovery and chemical engineering techniques. His rigorous academic training laid the groundwork for a prolific research trajectory, allowing him to merge fundamental scientific inquiry with industrially relevant challenges. Throughout his education, he cultivated expertise in computational modeling, reservoir simulation, and surfactant-fluid interactions, preparing him for an influential career in both academia and the energy sector.

Experience

Over the years, Dr. Ahmadi has held research and teaching roles that bridge academia and industry. His dual affiliation with the University of Calgary and the Petroleum University of Technology highlights his global influence and collaborative research ethos. He has independently led numerous projects that focus on oil recovery, nanoconfinement effects, interfacial science, and chemical processes in porous media. His hands-on experience spans experimental design, simulation modeling, and the application of artificial intelligence in reservoir characterization. Beyond research, Dr. Ahmadi has mentored graduate students, developed university curricula, and contributed as a reviewer for top-tier scientific journals.

Research Interest

Dr. Ahmadi’s research interests revolve around enhanced oil recovery (EOR), nanoconfinement phenomena, molecular dynamics (MD) simulations, and the environmental optimization of hydrocarbon production. He is particularly focused on the role of surfactants in emulsification-demulsification processes and their molecular behavior in subsurface environments. Other core interests include CO₂ sequestration, steam-surfactant co-injection, and machine learning applications in petroleum systems. His interdisciplinary approach—blending chemical engineering, geomechanics, and data science—enables him to address both theoretical and practical problems in energy sustainability.

Awards

Dr. Ahmadi has received several accolades in recognition of his groundbreaking research and scholarly contributions. His high citation count, an H-index of 60, and frequent collaboration with leading scientists highlight his standing in the scientific community. While specific award names are not detailed in the public record, his sustained publication in high-impact journals and the adoption of his findings in patent literature underscore his influence and merit for prestigious academic honors.

Publications

Among his extensive portfolio of over 180 works, several stand out for their impact and citation frequency.

His 2022 article, “Molecular dynamics simulation of oil detachment from hydrophobic quartz surfaces during steam-surfactant Co-injection” in Energy (cited 32 times), provides insights into recovery processes at the nanoscale. Another highly cited work, “Comprehensive review of the interfacial behavior of water/oil/surfactant systems using dissipative particle dynamics simulation,” published in Advances in Colloid and Interface Science (2022), has received 37 citations.

His 2021 paper in Fuel on surfactant-asphaltene interactions has been cited 72 times, reflecting its foundational contribution. The 2020 study in Energy & Fuels titled “Insight into the Interfacial Behavior of Surfactants and Asphaltenes” has been cited 58 times.

His 2021 article in Petroleum comparing permeability estimation methods has attracted 139 citations, showcasing his impact on reservoir engineering. “Challenges and future of chemical assisted heavy oil recovery processes,” published in 2020 in Advances in Colloid and Interface Science, is another well-cited piece with 104 references.

Lastly, his 2020 Symmetry publication on surfactant-asphaltene interactions in hydrocarbon solvents has been cited 44 times, reinforcing his expertise in interfacial behavior.

Conclusion

Dr. Mohammadali Ahmadi stands as a leading figure in the field of petroleum engineering and energy science. His ability to tackle intricate challenges using computational tools and experimental insights has not only enriched academic literature but also provided viable solutions for the energy industry. With a remarkable blend of scientific rigor, technical innovation, and interdisciplinary collaboration, Dr. Ahmadi continues to shape the future of enhanced oil recovery and sustainable energy processes. His qualifications, productivity, and scholarly excellence make him an outstanding candidate for any distinguished award in engineering and applied science.

Reiko Kiyonami | Well Testing and Analysis

Dr. Reiko Kiyonami | Well Testing and Analysis | Best Industrial Research Award

Senior Product Applications Specialist at Thermo Fisher Scientific, United States

Dr. Reiko Kiyonami is a distinguished scientist and senior product applications specialist at Thermo Fisher Scientific, with over three decades of dedicated service and innovation in the field of analytical chemistry. Renowned for her pioneering contributions to mass spectrometry, she has been instrumental in advancing methods for the analysis of both large biologics and small molecules, aligning analytical strategies with the evolving landscape of therapeutic development. Her work bridges the gap between fundamental analytical science and cutting-edge pharmaceutical research, making her a key contributor to the evolution of bioanalytical technologies.

Profile

Scopus

Education

Dr. Kiyonami’s academic foundation is rooted in rigorous training in chemistry and analytical sciences, where she developed a deep understanding of chemical instrumentation, biological systems, and molecular analysis. Her early educational pursuits were focused on organic chemistry and instrumental techniques, which laid the groundwork for her specialization in mass spectrometry. Her academic journey fostered an analytical mindset that would later propel her into a role at the forefront of applied mass spectrometry in pharmaceutical and biotechnology sectors.

Experience

Since joining Thermo Fisher Scientific in 1990, Dr. Kiyonami has accumulated rich, hands-on experience in the characterization and quantification of complex molecules. Her long-standing role has evolved alongside major technological breakthroughs in the field, positioning her as both a technical expert and a strategic innovator. Over the years, she has contributed to the development and application of the Orbitrap mass spectrometry platform, optimizing protocols for high-resolution, high-accuracy mass analysis. Her role involves extensive collaboration with academic and industry partners, where she provides critical insights into the challenges and solutions of biologics analysis, including monoclonal antibodies, fusion proteins, and novel modalities.

Research Interest

Dr. Kiyonami’s research interests center around developing analytical workflows for emerging therapeutic modalities such as antibody-drug conjugates (ADCs), bispecific antibodies, and gene therapy vectors. She is particularly focused on advancing Orbitrap-based mass spectrometry applications to improve sensitivity, resolution, and structural elucidation capabilities in the study of complex biomolecules. Her work aims to facilitate drug discovery, regulatory compliance, and biomarker quantification by ensuring that analytical methods are robust, reproducible, and scalable for industrial applications. Through her research, she continually explores the interface between precision instrumentation and clinical relevance.

Award

Throughout her career, Dr. Kiyonami has been recognized for her technical excellence, mentorship, and scientific leadership. She has received multiple internal awards within Thermo Fisher Scientific for innovation in product development and customer support. Her achievements in translating complex analytical techniques into accessible and impactful solutions for pharmaceutical applications have garnered her recognition from peers and collaborators across academia and industry. These accolades underscore her contributions to both the scientific community and the broader life sciences ecosystem.

Publication

Dr. Reiko Kiyonami has authored and co-authored numerous scientific publications that highlight her contributions to mass spectrometry applications. Selected works include: (1) “Characterization of Antibody-Drug Conjugates Using Orbitrap-Based Mass Spectrometry” in Journal of Proteome Research (2020), cited by 58 articles; (2) “Quantitative Analysis of Biotherapeutics by High-Resolution Mass Spectrometry” in Analytical Chemistry (2019), cited by 76 articles; (3) “New Strategies in Intact Protein Characterization: Orbitrap-Based Mass Analysis” in Bioanalysis (2018), cited by 42 articles; (4) “Advanced Workflows for Host Cell Protein Detection in Biologics” in mAbs (2021), cited by 39 articles; (5) “Top-Down and Middle-Down Approaches for Monoclonal Antibody Characterization” in Mass Spectrometry Reviews (2017), cited by 88 articles; (6) “Applications of Mass Spectrometry in the Analysis of Fusion Proteins” in Biotechnology Journal (2022), cited by 21 articles; and (7) “Analytical Performance of Orbitrap MS for Viral Vector Characterization” in Journal of Chromatography B (2023), cited by 15 articles. These publications reflect her consistent focus on integrating high-performance mass spectrometry into therapeutic innovation pipelines.

Conclusion

Dr. Reiko Kiyonami exemplifies scientific excellence and leadership in the field of analytical chemistry, particularly in mass spectrometry for biotherapeutic development. Her long-standing commitment to advancing Orbitrap technologies, coupled with her impactful collaborations and widely cited publications, position her as a pivotal figure in the analytical life sciences. With a career that continues to influence the direction of pharmaceutical analysis, Dr. Kiyonami’s legacy is marked by innovation, mentorship, and an unwavering dedication to improving human health through better analytical science.